MII IG Kerndatensatz-Modul Seltene Erkrankungen
2027.0.0-ballot -
Germany
This page is part of the MII Implementation Guide Seltene Erkrankungen (v2027.0.0-ballot: 2027 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
English
status: Active
medication: Losartan 50mg
effective: 2024-12-15
reasonReference: Condition Marfan syndrome
note:
Zur Progressionshemmung der Aortenwurzeldilatation bei Marfan-Syndrom
dosage
text: 50mg einmal täglich
timing: Once per 1 day
route: Oral route
DoseAndRates
Dose[x] 50 mg (Details: UCUM codemg = 'mg')